DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,978 filers reported holding DANAHER CORPORATION in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ZEVIN ASSET MANAGEMENT LLC | 66,948 | $16,973,000 | 3.83% |
| Miura Global Management | 22,000 | $5,577,000 | 3.82% |
| Ramsay, Stattman, Vela & Price, Inc. | 67,255 | $17,050,000 | 3.82% |
| Dempze Nancy E | 14,828 | $3,759,000 | 3.78% |
| Hemenway Trust Co LLC | 130,835 | $33,169,000 | 3.78% |
| MONTRUSCO BOLTON INVESTMENTS INC. | 569,508 | $141,550,000 | 3.77% |
| Sivik Global Healthcare LLC | 26,000 | $6,592,000 | 3.75% |
| DUNCKER STREETT & CO INC | 61,402 | $15,567,000 | 3.73% |
| Buffington Mohr McNeal | 66,558 | $16,874,000 | 3.70% |
| O'Brien Greene & Co. Inc | 38,273 | $9,702,000 | 3.66% |
| PUZO MICHAEL J | 40,312 | $10,221,000 | 3.63% |
| Mendel Money Management | 23,827 | $6,041,000 | 3.60% |
| Parkman Healthcare Partners LLC | 38,466 | $9,752,000 | 3.59% |
| Lipe & Dalton | 23,700 | $6,008,000 | 3.52% |
| McCollum Christoferson Group LLC | 44,881 | $11,378,000 | 3.47% |
| Kidder Stephen W | 35,110 | $8,901,000 | 3.45% |
| TANDEM CAPITAL MANAGEMENT CORP /ADV | 16,910 | $4,287,000 | 3.43% |
| Spears Abacus Advisors LLC | 149,543 | $37,912,000 | 3.42% |
| LS Investment Advisors, LLC | 71,818 | $18,207,000 | 3.39% |
| BRASADA CAPITAL MANAGEMENT, LP | 59,341 | $15,044,000 | 3.38% |
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
External links
This page lists DANAHER CORPORATION's shareholders in Q2 2022. To view DANAHER CORPORATION's shareholder history, click here.